Sunshine Biopharma Inc. (SBFMW) Net margin 2019–2025
Sunshine Biopharma Inc. (SBFMW) net profit margin by fiscal year — reported net income divided by reported revenue.
-16.5%FY2025 · since FY2019: -7860.9% → -16.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.5% | -1.7 pp |
| FY2024 | -14.7% | +4.0 pp |
| FY2023 | -18.7% | +596.7 pp |
| FY2022 | -615.4% | +4829.0 pp |
| FY2021 | -5444.4% | -1545.7 pp |
| FY2020 | -3898.7% | +3962.1 pp |
| FY2019 | -7860.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice